# Evaluate the Pharmacokinetics of Digoxin When Coadministered With PEX168 in Healthy Adult Subjects

> **NCT02472236** · PHASE1 · COMPLETED · sponsor: **Jiangsu Hansoh Pharmaceutical Co., Ltd.** · enrollment: 16 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** PEX168
- **DRUG:** Digoxin

## Key facts

- **NCT ID:** NCT02472236
- **Lead sponsor:** Jiangsu Hansoh Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-06-08
- **Primary completion:** 2015-09-24
- **Final completion:** 2016-01-18
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2017-01-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02472236

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02472236, "Evaluate the Pharmacokinetics of Digoxin When Coadministered With PEX168 in Healthy Adult Subjects". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02472236. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*